MTND3P4

Across TCGA pan-cancer cohorts, MTND3P4 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MTND3P4 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MTND3P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND3P4 expression acts as an unfavorable survival marker.

STAD, UCEC, and COAD are the cancer types where MTND3P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.302	0.721	.004	54	view →
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	54	view →
COAD	OS	Tertile	II,III,IV	0.233	0.788	.031	18	view →
HNSC	OS	Tertile	All	0.260	0.713	.012	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
SARC	OS	Tertile	All	0.183	0.827	<.001	18	view →
LUSC	OS	Tertile	All	0.360	0.727	.031	9	view →
LGG	OS	Tertile	All	0.644	0.908	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MTND3P4–STAD (DFS)

Open the STAD breakdown →